Mammography inspections reviewed in US
This article was originally published in Clinica
The US House last week voted to re-authorise the Mammography Quality Standards Act (MQSA), which requires annual inspections of the 10,000 mammography facilities in the United States by FDA-approved accreditation bodies. Since MQSA was enacted six years ago, the number of facilities unable to pass image quality tests has fallen from 11 percent to 2 percent.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.